News
Introduction of LUMICKS consumables and script-sharing platform to facilitate Dynamic Single-Molecule analysis
In a move to broadly unlock Dynamic Single-Molecule (DSM) analysis, LUMICKS simultaneously launched two major initiatives: a new business line for reagents, biochemistry kits, and services, as well as its Harbor platform for sharing of DSM scripts. These new resources dramatically simplify the experimental workflow and make DSM analysis accessible across different fields and expertise […]
News
Amsterdam UMC and AlphaBiomics initiate collaboration to validate biologics treatment response predictor RxSelexTM in patients suffering from inflammatory bowel disease
This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]
News
A story of VU startup Fitsurance
Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health, we stepped up our efforts to prepare for 2020, in order to make […]
News
Haermonics ontvangt investering voor betere zorg na openhartchirurgie
Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]
News
IXAnext Physics2Market grant and invitation to Round Table discussion for Chris Slootweg
Chris Slootweg (UvA) has been awarded an IXAnext Physics2Market grant for his work to use sodium borohydride as a carrier of hydrogen. For his expertise on the energy transition, especially in the field of hydrogen Slootweg has been invited to participate in the round-table discussion on the energy transition. Regeneration protocol to release hydrogen Hydrogen […]
News
Rewarded Take-off grants for Amsterdam projects
Various projects within the Amsterdam knowledge institutions have received funding through a Take-off program from NWO. With this funding, they can further investigate the market opportunities for their products through a feasibility study or with an early stage route. Projects Feasibility studies (phase 1) VU-AMS, Ambulatory Monitoring of the Autonomic Nervous System Hoofdaanvrager: Prof. dr. […]
News
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development. By quantifying binding strength between immune and cancer cells using the unique z-Movi® Cell Avidity Analyzer, Glycostem exploits the predictiveness of avidity in finding the best NK-cell population for cellular therapy. Glycostem is a leading NK-cell manufacturer that has […]
News
Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
News
Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
News
2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
News